NEW YORK - Nominations are currently being sought for the Paul Marks Prize for Cancer Research. This award, established by Memorial Sloan-Kettering Cancer Center in 2001 is named for Paul A. Marks, MD, President Emeritus of the Center and a distinguished scientist.
The prize recognizes outstanding young investigators who have made significant contributions to increase the understanding of cancer or improve the treatment of the disease through basic or clinical research.
The Paul Marks Prize is awarded to up to three investigators every other year. Nominees are required to be age 45 or younger at the time of the submission deadline. The winners will present their work at MSKCC and share a cash award of $150,000.
The winners of the 2003 Paul Marks Prize were: Yuan Chang, MD, Professor, University of Pittsburgh Cancer Institute; John F.X. Diffley, PhD, Principal Scientist, Cancer Research UK London Center; and Nikola Pavletich, PhD, Chairman of Structural Biology, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center. Learn more about the Paul Marks Prize.
Nomination packets must include a letter from the nominator outlining the significance of the accomplishments for which the candidate should be recognized. This should be accompanied by a one-page scientific biography of the candidate; a list of up to eight of the candidate's significant published papers with a brief (fewer than 100 words) explanation of the importance of each one; the candidate's curriculum vitae; and up to three supporting letters.
Nominations must be received by April 29, 2005. They should be sent to:
Paizhe Pressley Executive Assistant Office of the President Memorial Sloan-Kettering Cancer Center 1275 York Avenue New York, New York, 10065
Memorial Sloan-Kettering Cancer Center is the world's oldest and largest private institution devoted to prevention, patient care, research, and education in cancer. Our scientists and clinicians generate innovative approaches to better understand, diagnose and treat cancer. Our specialists are leaders in biomedical research and in translating the latest research to advance the standard of cancer care worldwide.
Journalists may contact the Department of Public Affairs for more information.
